N-Acetylaspartate as a reservoir for glutamate

Medical Hypotheses

Volumn 67, Issue 3, 2006, Pages 506-512

  Clark, Joseph F ^a   Doepke, Amos ^a   Filosa, Jessica A ^a   Wardle, Robert L ^b   Lu, Aigang ^a   Meeker, Timothy J ^a   Pyne Geithman, Gail J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ACETIC ACID; ACETYL COENZYME A; AMINO ACID DERIVATIVE; ASPARTIC ACID; ASPARTOACYLASE; CITRIC ACID; GLUTAMIC ACID; N ACETYLASPARTIC ACID; NEUROTRANSMITTER; OXALOACETIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO ACID METABOLISM; ARTICLE; ASTROCYTE; BRAIN METABOLISM; BRAIN MITOCHONDRION; CANAVAN DISEASE; CITRIC ACID CYCLE; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL; NEUROBIOLOGY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

ASPARTIC ACID; ASTROCYTES; BRAIN; CITRIC ACID CYCLE; DIPEPTIDES; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; NEURONS; NEUROTRANSMITTER AGENTS; OLIGODENDROGLIA;

EID: 33745266134     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.02.047     Document Type: Article

References (50)

1. Miller B.L. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline. NMR Biomed 4 2 (1991) 47-52
2. Vielhaber S., Kudin A.P., Kudina T.A., Stiller D., Scheich H., Schoenfeld A., et al. Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats. Eur J Neurosci 18 8 (2003) 2292-2300
3. Reichelt K.L., and Kvamme E. Acetylated and peptide bound glutamate and sapartate in brain. J Neurochem 14 10 (1967) 987-995
4. Truckenmiller M.E., Namboodiri M.A., Brownstein M.J., and Neale J.H. N-Acetylation of l-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 45 5 (1985) 1658-1662
5. Baslow M.H., Suckow R.F., Sapirstein V., and Hungund B.L. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes. J Mol Neurosci 13 1-2 (1999) 47-53
6. Kirmani B.F., Jacobowitz D.M., Kallarakal A.T., and Namboodiri M.A. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res Mol Brain Res 107 2 (2002) 176-182
7. Bhakoo K.K., and Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74 1 (2000) 254-262
8. Mehta V., and Namboodiri M.A. N-acetylaspartate as an acetyl source in the nervous system. Brain Res Mol Brain Res 31 1-2 (1995) 151-157
9. Barkhof F., and van Walderveen M. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance. Philos Trans R Soc Lond B Biol Sci 354 1390 (1999) 1675-1686
10. Jenkins B.G., Klivenyi P., Kustermann E., Andreassen O.A., Ferrante R.J., Rosen B.R., et al. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem 74 5 (2000) 2108-2119
11. Friedman S.D., Shaw D.W., Artru A.A., Richards T.L., Gardner J., Dawson G., et al. Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 60 1 (2003) 100-107
12. Usenius T., Usenius J.P., Tenhunen M., Vainio P., Johansson R., Soimakallio S., et al. Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo. Int J Radiat Oncol Biol Phys 33 3 (1995) 719-724
13. Mullins P.G., Rowland L., Bustillo J., Bedrick E.J., Lauriello J., and Brooks W.M. Reproducibility of 1H-MRS measurements in schizophrenic patients. Magn Reson Med 50 4 (2003) 704-707
14. Brooks W.M., Friedman S.D., and Stidley C.A. Reproducibility of 1H-MRS in vivo. Magn Reson Med 41 1 (1999) 193-197
15. Madhavarao C.N., Arun P., Moffett J.R., Szucs S., Surendran S., Matalon R., et al. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl Acad Sci USA 102 14 (2005) 5221-5226 Epub 2005 Mar 22
16. Baslow M.H., and Resnik T.R. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. J Mol Neurosci 9 2 (1997) 109-125
17. Baslow M.H. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation. J Mol Neurosci 21 3 (2003) 185-190
18. Wardlaw J.M., Marshall I., Wild J., Dennis M.S., Cannon J., and Lewis S.C. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy: relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 29 8 (1998) 1618-1624
19. Liu Y.J., Chen C.Y., Chung H.W., Huang I.J., Lee C.S., Chin S.C., et al. Neuronal damage after ischemic injury in the middle cerebral arterial territory: deep watershed versus territorial infarction at MR perfusion and spectroscopic imaging. Radiology 229 2 (2003) 366-374 Epub 2003 Sep 25
20. Madhavarao C.N., Chinopoulos C., Chandrasekaran K., and Namboodiri M.A. Characterization of the N-acetylaspartate biosynthetic enzyme from rat brain. J Neurochem 86 4 (2003) 824-835
21. Sibson N.R., Mason G.F., Shen J., Cline G.W., Herskovits A.Z., Wall J.E., et al. In vivo (13)C NMR measurement of neurotransmitter glutamate cycling, anaplerosis and TCA cycle flux in rat brain during. J Neurochem 76 4 (2001) 975-989
22. Kreibich T.A., Chalasani S.H., Raper J.A., Chatziioannou A., Palaiologos G., and Kolisis F.N. The neurotransmitter glutamate reduces axonal responsiveness to multiple repellents through the activation of metabotropic glutamate receptor 1. J Neurosci 24 32 (2004) 7085-7095
23. Seal R.P., and Edwards R.H. Functional implications of neurotransmitter co-release: glutamate and GABA share the load. Curr Opin Pharmacol 13 (2005) 13
24. Yudkoff M., Daikhin Y., Nissim I., Horyn O., Luhovyy B., and Lazarow A. Brain amino acid requirements and toxicity: the example of leucine. J Nutr 135 Suppl. 6 (2005) 1531S-1538S
25. Coyle J.T. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis 4 3-4 (1997) 231-238
26. Miller S.L., Daikhin Y., and Yudkoff M. Metabolism of N-acetyl-l-aspartate in rat brain. Neurochem Res 21 5 (1996) 615-618
27. Chakraborty G., Mekala P., Yahya D., Wu G., and Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 78 4 (2001) 736-745
28. George R.L., Huang W., Naggar H.A., Smith S.B., Ganapathy V., Wang H., et al. Transport of N-acetylaspartate via murine sodium/dicarboxylate cotransporter NaDC3 and expression of this transporter and aspartoacylase II in ocular tissues in mouse. Biochim Biophys Acta 1690 1 (2004) 63-69
29. Huang W., Wang H., Kekuda R., Fei Y.J., Friedrich A., Wang J., et al. Transport of N-acetylaspartate by the Na(+)-dependent high-affinity dicarboxylate transporter NaDC3 and its relevance to the expression of the transporter in the brain. J Pharmacol Exp Ther 295 1 (2000) 392-403
30. Baslow M.H. Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochem Int 40 4 (2002) 295-300
31. Baslow M.H., Dyakin V.V., Nowak K.L., Hungund B.L., and Guilfoyle D.N. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. J Mol Neurosci 26 1 (2005) 1-15
32. Karelson G., Ziegler A., Kunnecke B., and Seelig J. Feeding versus infusion: a novel approach to study the NAA metabolism in rat brain. NMR Biomed 16 6-7 (2003) 413-423
33. Gladden L.B. Lactate metabolism: a new paradigm for the third millennium. J Physiol 558 Pt 1 (2004) 5-30 Epub 2004 May 6
34. Aubert A., Costalat R., Magistretti P.J., and Pellerin L. Brain lactate kinetics: Modeling evidence for neuronal lactate uptake upon activation. Proc Natl Acad Sci USA 102 45 (2005) 16448-16453 Epub 2005 Oct 31
35. Jessen F., Traeber F., Freymann N., Maier W., Schild H.H., Heun R., et al. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease. Dement Geriatr Cogn Disord 20 2-3 (2005) 178-183 Epub 2005 Jul 15
36. Baslow M.H. Functions of N-acetyl-l-aspartate and N-acetyl-l-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 75 2 (2000) 453-459
37. Neale J.H., Bzdega T., and Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75 2 (2000) 443-452
38. Passani L.A., Vonsattel J.P., Carter R.E., and Coyle J.T. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases. Mol Chem Neuropathol 31 2 (1997) 97-118
39. Yan H.D., Ishihara K., Serikawa T., and Sasa M. Activation by N-acetyl-l-aspartate of acutely dissociated hippocampal neurons in rats via metabotropic glutamate receptors. Epilepsia 44 9 (2003) 1153-1159
40. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59 1 (1992) 55-61
41. Baslow M.H., and Guilfoyle D.N. Effect of N-acetylaspartic acid on the diffusion coefficient of water: a proton magnetic resonance phantom method for measurement of osmolyte-obligated water. Anal Biochem 311 2 (2002) 133-138
42. Hussy N., Bres V., Rochette M., Duvoid A., Alonso G., Dayanithi G., et al. Osmoregulation of vasopressin secretion via activation of neurohypophysial nerve terminals glycine receptors by glial taurine. J Neurosci 21 18 (2001) 7110-7116
43. Burri R., Steffen C., and Herschkowitz N. N-acetyl-l-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev Neurosci 13 6 (1991) 403-411
44. D'Adamo Jr. A.F., and Yatsu F.M. Acetate metabolism in the nervous system. N-acetyl-l-aspartic acid and the biosynthesis of brain lipids. J Neurochem 13 10 (1966) 961-965
45. Sager T.N., Thomsen C., Valsborg J.S., Laursen H., and Hansen A.J. Astroglia contain a specific transport mechanism for N-acetyl-l-aspartate. J Neurochem 73 2 (1999) 807-811
46. Bhakoo K.K., Craig T.J., and Styles P. Developmental and regional distribution of aspartoacylase in rat brain tissue. J Neurochem 79 1 (2001) 211-220
47. Kaul R., Casanova J., Johnson A.B., Tang P., and Matalon R. Purification, characterization, and localization of aspartoacylase from bovine brain. J Neurochem 56 1 (1991) 129-135
48. Mathew R., Arun P., Madhavarao C.N., Moffett J.R., and Namboodiri M.A. Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain. J Pharmacol Exp Ther 315 1 (2005) 297-303 Epub 2005 Jul 7
49. Sager T.N., Hansen A.J., and Laursen H. Correlation between N-acetylaspartate levels and histopathologic changes in cortical infarcts of mice after middle cerebral artery occlusion. J Cereb Blood Flow Metab 20 5 (2000) 780-788
50. Sager T.N., Fink-Jensen A., and Hansen A.J. Transient elevation of interstitial N-acetylaspartate in reversible global brain ischemia. J Neurochem 68 2 (1997) 675-682